share_log

申联生物(688098.SH):股东UBI拟减持不超3%股份

Shenlian Bio (688098.SH): shareholder UBI intends to reduce its stake by no more than 3%

格隆滙 ·  Dec 27, 2021 03:16

688098.SH announced that as of the date of this announcement, UBI, the shareholder of the company, held a total of 62.1385 million shares of the company, accounting for 15.13% of the total shares of the company. Due to the capital needs of shareholders' own development, UBI intends to reduce its holdings of no more than 12.3193 million shares of the company, that is, no more than 3 per cent of the company's total share capital, by means of centralized bidding and block trading. The reduction period shall be within 6 months after 15 trading days from the date of disclosure of this announcement.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment